DEFEROXAMINE MESYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Deferoxamine Mesylate patents expire, and when can generic versions of Deferoxamine Mesylate launch?
Deferoxamine Mesylate is a drug marketed by Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, and West-ward Pharms Int. and is included in five NDAs.
The generic ingredient in DEFEROXAMINE MESYLATE is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Deferoxamine Mesylate
A generic version of DEFEROXAMINE MESYLATE was approved as deferoxamine mesylate by HOSPIRA on March 17th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEFEROXAMINE MESYLATE?
- What are the global sales for DEFEROXAMINE MESYLATE?
- What is Average Wholesale Price for DEFEROXAMINE MESYLATE?
Summary for DEFEROXAMINE MESYLATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 6 |
| Patent Applications: | 1,420 |
| Drug Prices: | Drug price information for DEFEROXAMINE MESYLATE |
| DailyMed Link: | DEFEROXAMINE MESYLATE at DailyMed |
Recent Clinical Trials for DEFEROXAMINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Michigan Medicine PKUHSC Joint Institute for Translational & Clinical Research | Phase 2 |
| Aditya S. Pandey, MD | Phase 2 |
| People’s Hospital of Beijing Daxing District | Phase 1/Phase 2 |
Pharmacology for DEFEROXAMINE MESYLATE
| Drug Class | Iron Chelator |
| Mechanism of Action | Iron Chelating Activity |
Medical Subject Heading (MeSH) Categories for DEFEROXAMINE MESYLATE
Anatomical Therapeutic Chemical (ATC) Classes for DEFEROXAMINE MESYLATE
US Patents and Regulatory Information for DEFEROXAMINE MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | DEFEROXAMINE MESYLATE | deferoxamine mesylate | INJECTABLE;INJECTION | 076806-002 | Mar 31, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | DEFEROXAMINE MESYLATE | deferoxamine mesylate | INJECTABLE;INJECTION | 076019-002 | Mar 17, 2004 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | DEFEROXAMINE MESYLATE | deferoxamine mesylate | INJECTABLE;INJECTION | 078718-001 | Sep 15, 2009 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
